102 related articles for article (PubMed ID: 1860933)
1. Determination of the new anticancer agent KW 2149, 7-N-[2-[2-(gamma-L-glutamylamino)ethyl)dithio)ethyl]mitomycin C, an analogue of mitomycin C.
Pattyn G; van Oosterom AT; de Bruijn EA; Tjaden UR
J Chromatogr; 1991 Mar; 564(1):352-4. PubMed ID: 1860933
[TBL] [Abstract][Full Text] [Related]
2. Determination of mitomycin C in serum by high-performance liquid chromatography with dual-electrode coulometric detection.
Ohkubo T; Nambara T
J Chromatogr; 1990 May; 527(2):441-6. PubMed ID: 2117616
[No Abstract] [Full Text] [Related]
3. 7-N-(2-([2-(gamma-L-glutamylamino)-ethyl]-dithio)-ethyl)-mitomycin C (KW-2149) is more active than mitomycin C on chemonaive and drug-resistant urothelial carcinoma cells.
Rohde D; Raffenberg G; Kaviani S; Wolff J; Jakse G
Urol Res; 1998; 26(4):243-7. PubMed ID: 9759997
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
Tsuruo T; Sudo Y; Asami N; Inaba M; Morimoto M
Cancer Chemother Pharmacol; 1990; 27(2):89-93. PubMed ID: 2123421
[TBL] [Abstract][Full Text] [Related]
5. Nonenzymatic reductive activation of 7-N-((2-([2-(gamma-L-glutamylamino)ethyl]dithio)ethyl))mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C-resistant tumor cells.
Lee JH; Naito M; Tsuruo T
Cancer Res; 1994 May; 54(9):2398-403. PubMed ID: 8162587
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y
Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of the peptide-mitomycin KW-2149 and its metabolites in plasma by high-performance liquid chromatography.
Zhang ZD; Guetens G; De Boeck G; Van Cauwenberghe K; Maes RA; Ardiet C; van Oosterom AT; Highley M; de Bruijn EA; Tjaden UR
J Chromatogr B Biomed Sci Appl; 2000 Mar; 739(2):281-9. PubMed ID: 10755372
[TBL] [Abstract][Full Text] [Related]
8. KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithioethyl]mitomycin C). A new mitomycin C analogue activated by serum.
Masters JR; Know RJ; Hartley JA; Kelland LR; Hendriks HR; Connors T
Biochem Pharmacol; 1997 Feb; 53(3):279-85. PubMed ID: 9065731
[TBL] [Abstract][Full Text] [Related]
9. Reversed-phase high-performance liquid chromatographic determination of mitomycin C in human serum.
Buice RG; Sidhu P; Gurley BJ; Niell HB
Ther Drug Monit; 1984; 6(1):113-5. PubMed ID: 6424274
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of mitomycin C in dogs: application of a high-performance liquid chromatographic assay.
Barbhaiya RH; Papp EA; Van Harken DR; Smyth RD
J Pharm Sci; 1984 Sep; 73(9):1220-3. PubMed ID: 6436466
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of 7-N-(2-((2-(-gamma-L-glutamylamino)- ethyl)dithio)ethyl)-mitomycin C and metabolites in cell lines with different resistance patterns.
Dirix LY; Gheuens EE; van der Heyden S; van Oosterom AT; De Bruijn EA
Anticancer Drugs; 1994 Jun; 5(3):343-54. PubMed ID: 7919460
[TBL] [Abstract][Full Text] [Related]
12. Circumvention of glutathione-mediated mitomycin C resistance by a novel mitomycin C analogue, KW-2149.
Ishida T; Nishio K; Kurokawa H; Arioka H; Fukumoto H; Fukuoka K; Nomoto T; Yokote H; Hasegawa S; Saijo N
Int J Cancer; 1997 Sep; 72(5):865-70. PubMed ID: 9311606
[TBL] [Abstract][Full Text] [Related]
13. Structural determination of the conjugate of human serum albumin with a mitomycin C derivative, KW-2149, by matrix-assisted laser desorption/ionization mass spectrometry.
Yasuzawa T; Tomer KB
Bioconjug Chem; 1997; 8(3):391-9. PubMed ID: 9177846
[TBL] [Abstract][Full Text] [Related]
14. Sensitive and convenient high-performance liquid chromatographic method for the determination of mitomycin C in human plasma.
Joseph G; Biederbick W; Woschée U; Theisohn M; Klaus W
J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):261-7. PubMed ID: 9367216
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of 7-N-(2-((2-(gamma-L-glutamylamino) ethyl) dithio) ethyl) mitomycin C (KW2149) against human tumor xenografts serially transplanted into nude mice.
Kubota T; Inada T; Inoue S; Kuzuoka M; Arisawa Y; Suto A; Kodaira S; Ishibiki K; Abe O
Jpn J Clin Oncol; 1989 Sep; 19(3):216-21. PubMed ID: 2554025
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of a novel water soluble mitomycin analog; 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C.
Kono M; Saitoh Y; Kasai M; Sato A; Shirahata K; Morimoto M; Ashizawa T
Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1128-30. PubMed ID: 2766417
[TBL] [Abstract][Full Text] [Related]
17. KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithioethyl] mitomycin C): DNA interactions and drug uptake following serum activation.
McAdam SR; Knox RJ; Hartley JA; Masters JR
Biochem Pharmacol; 1998 Jun; 55(11):1777-83. PubMed ID: 9714295
[TBL] [Abstract][Full Text] [Related]
18. Mitomycin C determination using loop-column extraction: a rapid and sensitive high-performance liquid chromatographic assay for pharmacokinetic studies with Spherex starch particles.
Czejka MJ; Jäger W; Schüller J
J Chromatogr; 1989 Dec; 497():336-41. PubMed ID: 2516522
[No Abstract] [Full Text] [Related]
19. Determination of mitomycin C in plasma, serum and urine by high-performance liquid chromatography with ultra-violet and electrochemical detection.
Tjaden UR; Langenberg JP; Ensing K; van Bennekom WP; de Bruijn EA; van Oosterom AT
J Chromatogr; 1982 Nov; 232(2):355-67. PubMed ID: 6818240
[TBL] [Abstract][Full Text] [Related]
20. Liquid chromatography-thermospray mass spectrometry of DNA adducts formed with mitomycin C, porfiromycin and thiotepa.
Musser SM; Pan SS; Callery PS
J Chromatogr; 1989 Jul; 474(1):197-207. PubMed ID: 2504760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
